Patents Assigned to MedGenome Inc.
  • Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore
    Patent number: 10350280
    Abstract: The invention describes a method for identifying T-cell activating neo-epitopes from all genetically altered proteins. The mutated proteins contribute to neo-epitopes after they are proteolytically degraded within antigen presenting cells, such as dendritic cells and macrophages.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: July 16, 2019
    Assignee: MedGenome Inc.
    Inventors: Amitabha Chaudhuri, Ravi Gupta, Priyanka Shah, Malini Manoharan, Kiran V. Paul, Rohit Gupta